ZYXI Logo

Zynex, Inc. (ZYXI) 

NASDAQ
Market Cap
$263.68M
Sector
Healthcare
Industry
Medical—Distribution
Rank in Sector
324 of 958
Rank in Industry
3 of 9

Largest Insider Buys in Sector

ZYXI Stock Price History Chart

ZYXI Stock Performance

About Zynex, Inc.

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; …

Insider Activity of Zynex, Inc.

Over the last 12 months, insiders at Zynex, Inc. have bought $58,233 and sold $698,990 worth of Zynex, Inc. stock.

On average, over the past 5 years, insiders at Zynex, Inc. have bought $53,864 and sold $14.01M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Disbrow Joshua R. (director) — $116,466.

The last purchase of 7,000 shares for transaction amount of $58,233 was made by Disbrow Joshua R. (director) on 2024‑07‑29.

List of Insider Buy and Sell Transactions, Zynex, Inc.

2024-12-02SaleCHIEF FINANCIAL OFFICER
10,000
0.0308%
$8.08$80,800-0.73%
2024-11-14SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0064%
$8.09$16,1800.00%
2024-11-13SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0065%
$8.37$16,740+0.92%
2024-11-12SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0068%
$9.24$18,480-4.43%
2024-11-11SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0062%
$9.09$18,180-11.77%
2024-11-08SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0061%
$8.77$17,540-8.77%
2024-11-07SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0065%
$9.17$18,340-6.91%
2024-11-06SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0061%
$8.82$17,640-10.75%
2024-11-05SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0063%
$8.05$16,1000.00%
2024-11-04SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0068%
$8.67$17,340+2.94%
2024-11-01SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0062%
$8.63$17,260-6.16%
2024-11-01SaleCHIEF FINANCIAL OFFICER
10,000
0.0308%
$8.59$85,900-6.16%
2024-10-31SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0064%
$8.82$17,640-4.58%
2024-10-30SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0062%
$8.92$17,840-8.54%
2024-08-07SaleCHIEF OPERATING OFFICER
8,083
0.0255%
$8.03$64,906+0.75%
2024-08-06SaleCHIEF OPERATING OFFICER
16,792
0.0532%
$8.01$134,504+1.13%
2024-07-30SaleCHIEF FINANCIAL OFFICER
15,000
0.0474%
$8.24$123,600+1.33%
2024-07-29Purchasedirector
7,000
0.022%
$8.32$58,233-3.36%
2023-08-04SaleChief Financial Officer
20,000
0.056%
$8.49$169,800+20.77%
2023-08-04SaleChief Operating Officer
12,000
0.0333%
$8.41$100,920+20.77%

Insider Historical Profitability

30.13%
Sandgaard ThomasPRESIDENT, CEO AND CHAIRMAN
14603662
45.8579%
$8.282150
Disbrow Joshua R.director
72000
0.2261%
$8.2810
MOORHEAD DANIEL JCHIEF FINANCIAL OFFICER
35190
0.1105%
$8.28214+30.13%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$16.51M4.21.33M-7.92%-$1.42M<0.0001
The Vanguard Group$14.68M3.741.19M+0.52%+$75,419.89<0.0001
Arrowstreet Capital, Limited Partnership$7.11M1.81574,8870%+$00.01
Nantahala Capital Management Llc$6.06M1.54490,000+308.33%+$4.58M0.28
Hotchkis & Wiley Capital Management$5.35M1.36432,180New+$5.35M0.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.